Article
Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
Blood cells, molecules & diseases - 1 Jan 2000
Alfonso Pilar, Pampín Sandra, Estrada Jorge, Rodríguez-Rey José Carlos, Giraldo Pilar, Sancho Javier, Pocoví Miguel
Abstract excerpt
Gaucher disease (GD) is a disorder of glycosphinglipid metabolism caused by deficiency of lysosomal acid beta-glucosidase (GC), resulting in progressive deposition of glucosylceramide in macrophages. The glucose analogue, N-butyl-deoxynojirimycin (NB-DNJ, Miglustat), is an inhibitor of the ceramide-specific glucosyltransferase (CSG) which catalyzes the first step of glycosphingolipids biosynthesis and is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
